Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOTTA)
Recruiting now · Not applicable
Conditions studied: Chronic Pancreatitis, Surgery, Minimally Invasive Surgical Technique, Robot Surgica, Robot Surgery, Minimally Invasive Surgery, Pancreaticojunostomy
In brief
PANACOTTA is a multicenter randomized controlled trial including patients with symptomatic chronic pancreatitis and a dilated main pancreatic duct to either robot-assisted or open lateral pancreaticojejunostomy. The PANACOTTA trial will assess the post-operative quality of recovery following robot-assisted versus open lateral pancreaticojejunostomy.
Key facts
- Study ID
- NCT07109180
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- People needed
- 28
- Starts
- 2025-04-16
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-08-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- At least 18 years old
- Indication for (extended or partial) lateral pancreaticojejunostomy as agreed during multidisciplinary team meeting based on symptomatic chronic pancreatitis (i.e. morphine dependent pain or recurrent acute flares of pancreatitis, at least 3 episodes per year) and a dilated pancreatic duct of ≥ 5 mm, with a non-enlarged pancreatic head < 40 mm
- Confirmed CP, according to the M-ANNHEIM diagnostic Criteria24
- Eligible for both an robot-assisted and open approach
- Obtained written informed consent
You may not qualify if…
- Suspected or confirmed current pancreatic cancer
- ASA classification ≥ 4
- Other painful conditions aside from CP, with pain difficult to discriminate from CP pain
- Prior pancreatic surgery
- Pregnancy
Where it is running
- Amsterdam UMC — Amsterdam, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.